Identification of potential anticancer compounds from Oplopanax horridus

Phytomedicine

Volumn 20, Issue 11, 2013, Pages 999-1006

  Wang, Chong Zhi ^a   Zhang, Zhiyu ^a   Huang, Wei Hua ^b   Du, Guang Jian ^a   Wen, Xiao Dong ^a   Calway, Tyler ^a   Yu, Chunhao ^a   Nass, Rachael ^a   Zhao, Jing ^b   Du, Wei ^c   Li, Shao Ping ^b   Yuan, Chun Su ^a,d  

^a UNIVERSITY OF CHICAGO   (United States)

^b University of Macau   (Macao)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Anticancer; Apoptosis; Cell cycle; Falcarindiol; Oplopanax horridus; Oplopantriol A; Phytochemistry; Polyynes; Structure activity relationship

Indexed keywords

9,17 OCTADECADIENE 12,14 DIYNE 1,11,16 TRIOL 1 ACETATE; ANTINEOPLASTIC AGENT; BETA DAUCOSTEROL; CAFFEIC ACID; FALCARINDIOL; FERULIC ACID; OPLOPANDIOL; OPLOPANDIOL ACETATE; OPLOPANPHESIDE A; OPLOPANPHESIDE B; OPLOPANPHESIDE C; OPLOPANTRIOL A; OPLOPANTRIOL B; SITOSTEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; COLORECTAL CANCER; CONTROLLED STUDY; DRUG IDENTIFICATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OPLOPANAX; OPLOPANAX HORRIDUS; PRIORITY JOURNAL; RAT; TUMOR XENOGRAFT;

ANTICANCER; APOPTOSIS; CELL CYCLE; FALCARINDIOL; OPLOPANAX HORRIDUS; OPLOPANTRIOL A; PHYTOCHEMISTRY; POLYYNES; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DIYNES; FATTY ALCOHOLS; FEMALE; HETEROGRAFTS; HUMANS; MICE; MICE, NUDE; OPLOPANAX; PHYTOTHERAPY; PLANT EXTRACTS;

MUS MUSCULUS; OPLOPANAX HORRIDUS;

EID: 84880778559     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2013.04.013     Document Type: Article

References (30)

1. R.M. Bell A review of complementary and alternative medicine practices among cancer survivors Clinical Journal of Oncology Nursing 14 2010 365 370
2. T.A. Buchholz Radiation therapy for early-stage breast cancer after breast-conserving surgery The New England Journal of Medicine 360 2009 63 70
3. T. Calway, G.J. Du, C.Z. Wang, W.H. Huang, J. Zhao, S.P. Li, and C.S. Yuan Chemical and pharmacological studies of Oplopanax horridus, a North American botanical Journal of Natural Medicines 66 2012 249 256
4. G.M. Cragg, P.G. Grothaus, and D.J. Newman Impact of natural products on developing new anti-cancer agents Chemical Reviews 109 2009 3012 3043
5. E.L. Davis, B. Oh, P.N. Butow, B.A. Mullan, and S. Clarke Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review The Oncologist 17 2012 1475 1481
6. F.V. Din, M.G. Dunlop, and L.A. Stark Evidence for colorectal cancer cell specificity of aspirin effects on NF kappa B signalling and apoptosis British Journal of Cancer 91 2004 381 388 (Pubitemid 39037087)
7. W.N. Hait, and T.W. Hambley Targeted cancer therapeutics Cancer Research 69 2009 1263 1267 (discussion 1267)
8. B.C. He, J.L. Gao, B.Q. Zhang, Q. Luo, Q. Shi, S.H. Kim, E. Huang, Y. Gao, K. Yang, E.R. Wagner, L. Wang, N. Tang, J. Luo, X. Liu, M. Li, Y. Bi, J. Shen, G. Luther, N. Hu, Q. Zhou, H.H. Luu, R.C. Haydon, Y. Zhao, and T.C. He Tetrandrine inhibits Wnt/beta-catenin signaling and suppresses tumor growth of human colorectal cancer Molecular Pharmacology 79 2011 211 219
9. Huang, W.H., 2012. Chemical Investigation on Root Barks of Oplopanax horridus. Ph.D. Thesis, University of Macau, Macau, 268 pp.
10. W.H. Huang, Q.W. Zhang, L.Z. Meng, C.S. Yuan, C.Z. Wang, and S.P. Li Oplopanphesides A-C, three new phenolic glycosides from the root barks of Oplopanax horridus Chemical and Pharmaceutical Bulletin 59 2011 676 679
11. W.H. Huang, Q.W. Zhang, C.Z. Wang, C.S. Yuan, and S.P. Li Isolation and identification of two new polyynes from a North American ethnic medicinal plant - Oplopanax horridus (Smith) Miq Molecules 15 2010 1089 1096
12. R.N. Kharwar, A. Mishra, S.K. Gond, A. Stierle, and D. Stierle Anticancer compounds derived from fungal endophytes: their importance and future challenges Natural Product Reports 28 2011 1208 1228
13. M. Kobaisy, Z. Abramowski, L. Lermer, G. Saxena, R.E. Hancock, G.H. Towers, D. Doxsee, and R.W. Stokes Antimycobacterial polyynes of Devil's Club (Oplopanax horridus), a North American native medicinal plant Journal of Natural Products 60 1997 1210 1213 (Pubitemid 27516227)
14. T.C. Lantz, K. Swerhun, and N.J. Turner Devil's club (Oplopanax horridus): An ethnobotanical review Herbal Gram 62 2004 33 48
15. J.G. Lin, and Y.H. Chen The role of acupuncture in cancer supportive care The American Journal of Chinese Medicine 40 2012 219 229
16. A.R. McCutcheon, T.E. Roberts, E. Gibbons, S.M. Ellis, L.A. Babiuk, R.E. Hancock, and G.H. Towers Antiviral screening of British Columbian medicinal plants Journal of Ethnopharmacology 49 1995 101 110 (Pubitemid 26010743)
17. R.E. Minto, and B.J. Blacklock Biosynthesis and function of polyacetylenes and allied natural products Progress in Lipid Research 47 2008 233 306
18. P. Palozza, C. Torelli, A. Boninsegna, R. Simone, A. Catalano, M.C. Mele, and N. Picci Growth-inhibitory effects of the astaxanthin-rich alga Haematococcus pluvialis in human colon cancer cells Cancer Letters 283 2009 108 117
19. X. Paoletti, K. Oba, T. Burzykowski, S. Michiels, Y. Ohashi, J.P. Pignon, P. Rougier, J. Sakamoto, D. Sargent, M. Sasako, E. Van Cutsem, and M. Buyse Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis JAMA 303 2010 1729 1737
20. N. Radic, and B. Strukelj Endophytic fungi: the treasure chest of antibacterial substances Phytomedicine 19 2012 1270 1284
21. M.A. Randhawa, and M.S. Alghamdi Anticancer activity of Nigella sativa (black seed) - a review The American Journal of Chinese Medicine 39 2011 1075 1091
22. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics CA: A Cancer Journal for Clinicians 62 2012 10 29
23. S. Sun, G.J. Du, L.W. Qi, S. Williams, C.Z. Wang, and C.S. Yuan Hydrophobic constituents and their potential anticancer activities from Devil's Club (Oplopanax horridus Miq.) Journal of Ethnopharmacology 132 2010 280 285
24. S. Sun, X.L. Li, C.Z. Wang, S. Williams, and C.S. Yuan Improving anticancer activities of Oplopanax horridus root bark extract by removing water-soluble components Phytotherapy Research 24 2010 1166 1174
25. J. Tai, S. Cheung, S. Cheah, E. Chan, and D. Hasman In vitro anti-proliferative and antioxidant studies on Devil's Club Oplopanax horridus Journal of Ethnopharmacology 108 2006 228 235 (Pubitemid 44635035)
26. H. Wagner, and G. Ulrich-Merzenich Evidence and Rational Based Research on Chinese Drugs 2013 Springer New York 525 (Chapter 1, p. 1-25)
27. C.Z. Wang, H.H. Aung, S.R. Mehendale, Y. Shoyama, and C.S. Yuan High performance liquid chromatographic analysis and anticancer potential of Oplopanax horridus: comparison of stem and berry extracts Fitoterapia 81 2010 132 139
28. C.Z. Wang, T. Calway, and C.S. Yuan Herbal medicines as adjuvants for cancer therapeutics The American Journal of Chinese Medicine 40 2012 657 669
29. C.Z. Wang, G.J. Du, Z. Zhang, X.D. Wen, T. Calway, Z. Zhen, M.W. Musch, M. Bissonnette, E.B. Chang, and C.S. Yuan Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer International Journal of Oncology 40 2012 1970 1976
30. Z. Xu, X. Chen, Z. Zhong, L. Chen, and Y. Wang Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities The American Journal of Chinese Medicine 39 2011 15 27